Back to All Events
In this talk, BLOODPAC's Executive Director will discuss the organization's progress in:
(1) Educating the liquid biopsy community on evidence-based clinical utility and healthcare satisfaction
(2) Democratizing access to tests to improve patient outcomes
(3) Adopting liquid biopsy access approaches through the improvement of frameworks for access
(4) Evalutating the use of current regulation for adequate ctDNA access.
Previous
Previous
October 23
Focused Ultrasound and Liquid Biopsy - 2022 Symposium
Next
Next
March 6

